Search results
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoNew York, USA, May 02, 2024 (GLOBE NEWSWIRE) -- Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli
Omvoh cost 2024: Coupons and more
Medical News Today· 7 days agoGet the facts on cost and Omvoh, how generics compare with brand names, what financial assistance may be available, and more.
Inflammatory fibroblasts remodeling in colitis - Nature Immunology
Nature· 6 days agoInflammatory bowel diseases (IBDs) are characterized by waves of relapse and remitting inflammation that lead to the remodeling of the cellular diversity of the gut. In Cell, Paolo Cadinu at ...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 6 days agoAbbVie is also advancing its monoclonal antibody, ABT 981 (lutikizumab) in several indications like Crohn’s disease, inflammatory bowel disease, ...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 6 days agoAs of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market share...
Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide...
NBC 17 Raleigh· 7 days agoImmunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today ...
Researchers Engineer Yeast to Transport Medicines and Lower Inflammation for Potential Treatment of...
Newswise· 22 hours agoWith available medications sometimes causing serious side effects or losing their efficacy over...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 7 days agoSales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition from cheaper...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 4 days agoJ&J filed regulatory applications to the European Medicines Agency (EMA) seeking approval for its...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
NBC San Diego· 7 days agoSales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition from cheaper...
